Induction of prophages of enterohemorrhagic Escherichia coli O157:H7 with norfloxacin

Journal of Bacteriology

Volumn 181, Issue 7, 1999, Pages 2257-2260

  Matsushiro, Aizo ^a   Sato, Koki ^a   Miyamoto, Hiroshi ^a   Yamamura, Tadashi ^a   Honda, Takeshi ^a,b  

^a KINKI UNIVERSITY   (Japan)

^b OSAKA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

NORFLOXACIN;

ANTIBACTERIAL ACTIVITY; ARTICLE; DIARRHEA; ENZYME ACTIVITY; ESCHERICHIA COLI; GENE EXPRESSION; GENOME; HEMOLYTIC UREMIC SYNDROME; HEMORRHAGIC COLITIS; JAPAN; PRIORITY JOURNAL; PROPHAGE; REPRESSOR GENE; SHIGELLA; SPECIES DIFFERENCE;

ESCHERICHIA COLI; NEGIBACTERIA; PROKARYOTA; SHIGELLA; UNIDENTIFIED BACTERIOPHAGE;

EID: 0032932223     PISSN: 00219193     EISSN: None     Source Type: Journal    
DOI: 10.1128/jb.181.7.2257-2260.1999     Document Type: Article

References (24)

1. Al-Jumaili, I., D. A. Burke, S. M. Scotland, H. M. Al-Mardini, and C. O. Record. 1992. A method of enhancing verocytotoxin production by Escherichia coli. FEMS Microbiol. Lett. 93:121-126.
2. Craig, N. L., and J. W. Roberts. 1980. E. coli recA protein-directed cleavage of phage λ repressor requires polynucleotide. Nature 283:26-30.
3. De Grandis, S., J. Ginsberg, M. Toone, S. Climie, J. Friesen, and J. Brunton. 1987. Nucleotide sequence and promoter mapping of the Escherichia coli Shiga-like toxin operon of bacteriophage H-19B. J. Bacteriol. 169:4313-4319.
4. Endo, Y., K. Tsurugi, T. Yutsudo, Y. Takeda, T. Ogasawara, and K. Igarashi. 1988. Site of action of a Vero toxin (VT2) from Escherichia coli O157: H7 and of Shiga toxin on eukaryotic ribosomes RNA N-glycosidase activity of the toxins. Eur. J. Biochem. 171:45-50.
5. Hanna, W. T., S. Kraus, R. F. Regestger, and W. M. Murphy. 1981. Renal disease after mitomycin C therapy. Cancer 48:2583-2588.
6. Herskowitz, I., and E. Signer. 1970. A site essential for expression of all late genes in bacteriophage lambda. J. Mol. Biol. 47:545-556.
7. Hirai, K., H. Aoyama, S. Suzue, T. Irikura, S. Iyobe, and S. Mitsuhashi. 1986. Isolation and characterization of norfloxacin-resistant mutants of Escherichia coli K-12. Antimicrob. Agents Chemother. 30:248-253.
8. Ismaili, A., D. J. Philpott, M. T. Dytoc, and P. M. Sherman. 1995. Signal transduction responses following adhesion of verocytotoxin-producing Escherichia coli. Infect. Immun. 63:3316-3326.
9. Karch, H., N. A. Strockbine, and A. D. O'Brien. 1986. Growth of Escherichia coli in the presence of trimethoprim-sulfamethoxazole facilitates detection of Shiga-like toxin producing strains by colony blot assay. FEMS Microbiol. Lett. 35:141-145.
10. Lesene, J. B., N. Rothschild, B. Erickson, S. Korec, R. Sisk, J. Keller, M. Arbus, P. V. Woolley, L. Chiazze, P. S. Schein, and J. R. Neefe. 1989. Cancer-associated hemolytic-uremic syndrome: an analysis of 85 cases from a National Registry. J. Clin. Oncol. 7:781-789.
11. Makino, K., K. Ishii, T. Yasunaga, M. Hattori, K. Yokoyama, C. H. Yutsudo, Y. Kubota, Y. Yamaichi, T. Iida, K. Yamamoto, T. Honda, C.-G. Han, E. Ohtsubo, M. Kasamatsu, T. Hayashi, S. Kuhara, and H. Shinagawa. 1998. Complete nucleotide sequences of 93-kb and 3.3-kb plasmids of an enterohemorrhagic Escherichia coli O157:H7 derived from Sakai outbreak. DNA Res. 5:1-9.
12. McDaniel, T. K., K. G. Jarvis, M. S. Donnenberg, and J. B. Kaper. 1995. A genetic locus of enterocyte effacement conserved among diverse enterobacterial pathogens. Proc. Natl. Acad. Sci. USA 92:1664-1668.
13. Ministry of Health and Welfare, Japan. 1996. The guideline on the treatment of O157 infection for primary and secondary medical facilities (The Research Group on Diagnosis and Treatment of Enterohemorrhagic Escherichia coli Infection; group leader, Yoshifumi Takeda). Jpn. J. Bacteriol. 51:1096-1098. (In Japanese.)
14. Miyamoto, H., W. Nakai, N. Yazima, and A. Matsushiro. 1999. Complete nucleotide sequence of stx-converting phage VT2 of an EHEC O157, p. 33. In The Second Workshop of the Frontier Genome Research on Microorganisms, Osaka, Japan.
15. Mühldorfer, I., J. Hacker, G. T. Keuach, D. W. Acheson, H. Tschäpe, A. V. Kane, A. Ritter, T. Ölschläger, and A. Donohue-Rolfe. 1996. Regulation of the Shiga-like toxin II operon in Escherichia coli. Infect. Immun. 64:495-502.
16. Neely, M. N., and D. I. Friedman. 1998. Functional and genetic analysis of regulatory regions of coliphage H-19B: location of shiga-like toxin and lysis genes suggest a role for phage functions in toxin release. Mol. Microbiol. 28:1255-1267.
17. O'Brien, A. D., V. L. Tesh, A. Donohue-Rolfe, M. P. Jachson, S. Olsnes, K. Sandrig, A. A. Lindberg, and G. T. Keusch. 1992. Pathogenesis of shigellosis: Shiga toxin: biochemistry, genetics, mode of action and role in pathogenesis. Curr. Top. Microbiol. Immunol. 180:65-94.
18. Ogawa, T., H. Wabiko, T. Tsurimoto, T. Horii, H. Matsukata, and H. Ogawa. 1978. Characteristics of purified recA protein and the regulation of its synthesis in vivo. Cold Spring Harbor Symp. Quant. Biol. 43:909-915.
19. Roberts, J. W., C. W. Roberts, and N. L. Craig. 1978. Escherichia coli recA gene product inactivates phage lambda repressor. Proc. Natl. Acad. Sci. USA 75:4714-4718.
20. Sato, K., and A. Campbell. 1970. Specialized transduction of galactose by lambda phage from a deletion lysogen. Virology 41:474-487.
21. Takeda, Y., K. Okamoto, and T. Miwatani. 1979. Mitomycin C stimulates production of a toxin in Shigella species that causes morphological changes in Chinese hamster ovary cells. Infect. Immun. 23:178-180.
22. Walterspiel, J. N., S. Ashkenazi, A. L. Morrow, and T. G. Cleary. 1992. Effect of subinhibitory concentration of antibiotics on extra-cellular Shiga-like toxin I. Infection 20:25-29.
23. Willmott, C. J., and A. Maxwell. 1993. A single point mutation in the DNA gyrase A protein greatly reduces binding of fluoroquinolones to the gyrase-DNA complex. Antimicrob. Agents Chemother. 37:126-127.
24. Yee, A. J., S. De Grandis, and C. L. Gyles. 1993. Mitomycin-induced synthesis of a Shiga-like toxin from enteropathogenic Escherichia coli H.I.8. Infect. Immun. 61:4510-4513.